Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Macrogenics (MGNX)

Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Macrogenics 9704 MEDICAL CENTER DRIVE Rockville MD 20850 USA

www.macrogenics.com Employees: 341 P: 301-251-5172 F: 301-251-5321

Sector:

Medical

Description:

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 110,703
Enterprise Value, $K -72,137
Shares Outstanding, K 63,259
Float, K 55,035
% Float 87.00%
Short Interest, K 4,154
Short Float 6.57%
Days to Cover 3.75
Short Volume Ratio 0.41
% of Insider Shareholders 13.00%
% of Institutional Shareholders 96.89%

Financials:

Annual Sales, $ 149,960 K
Annual Net Income, $ -66,970 K
Last Quarter Sales, $ 72,840 K
Last Quarter Net Income, $ 16,820 K
EBIT, $ -113,580 K
EBITDA, $ -108,850 K

Growth:

1-Year Return -34.72%
3-Year Return -71.17%
5-Year Return -93.27%
5-Year Revenue Growth 133.62%
5-Year Earnings Growth 66.14%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.27 on 11/12/25
Next Earnings Date 03/19/26 [--]
Earnings Per Share ttm -1.20
EPS Growth vs. Prev Qtr 147.37%
EPS Growth vs. Prev Year -70.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MGNX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -98.30%
Return-on-Assets % -30.28%
Profit Margin % -44.66%
Debt/Equity 0.00
Price/Sales 0.88
Price/Cash Flow N/A
Price/Book 1.60
Book Value/Share 1.06
Interest Coverage -57.95
60-Month Beta 1.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar